|

Diabetes Clinical Trials in Austin, TX

29 recruiting studies within 50 miles

Phase
Trial Phase Dist.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 3<1 mi
Maternal Abdominal Morphology Assessment—<1 mi
Diabetes Prevention in Hispanic Adults Using Constant Glucose MonitorsN/A<1 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesN/A<1 mi
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesN/A<1 mi
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Phase 3<1 mi
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal InsulinPhase 2<1 mi
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With DiabetesN/A<1 mi
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic TargetsPhase 2<1 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 2<1 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesPhase 3<1 mi
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related ComorbidityPhase 2<1 mi
Fenofibrate for Prevention of DR WorseningPhase 3<1 mi
Balance Control and Recovery in Diabetes Peripheral NeuropathyN/A<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2<1 mi
Registry for Stage 2 Type 1 Diabetes—<1 mi
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based TherapyPhase 2<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesPhase 2<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPhase 3<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/2<1 mi
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular EdemaPhase 2/3<1 mi
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesPhase 4<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesPhase 3<1 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightPhase 3<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing DialysisPhase 2/3<1 mi
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerPhase 1/2<1 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatidePhase 217 mi
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.Phase 429 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/A29 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.